EP3192809 - Bibliographic data
ANTICORPS BISPÉCIFIQUES ANTI-BAFF-ANTI-IL-17
| Last update | 22/05/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Européen |
| (73) Holder |
Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Allan Barrett c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, IN 46206-6288
États-Unis d'Amérique
Robert Jan Benschop c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, IN 46206-6288
États-Unis d'Amérique
Lu Jirong c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, IN 46206-6288
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient O'Connor, David Eli Lilly and Company Limited
8 Arlington Square West Downshire Way
Bracknell, Berkshire RG12 1PU
Royaume-Uni
|
| (21) Request number | EP17153380.5 |
|---|---|
| (22) Request date | 16/04/2013 |
| (11) Publication number | EP3192809 |
|---|---|
| Publication date | 15/04/2020 |
| (54) Title of the invention | ANTICORPS BISPÉCIFIQUES ANTI-BAFF-ANTI-IL-17 |
|---|---|
| (51) International classification | C07K 16/24, C07K 16/28, C07K 16/46 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201261636302 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 8 -
Amount: 140 € -
Due date 15/06/2020
Surtax: 8 - Amount: 28 € - Due date 16/12/2020 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 15/04/2020 Entrée en période de grâce du brevet d'invention - Legal date 16/06/2020 Déchéance du brevet d'invention après période de grâce - Legal date 15/06/2020 |